Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
About this study
TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.
- Condition
- Rectal Cancer Patients, Robotic Assisted Intervention
- Tested
- robotic surgery vs transanal total mesorectal excsion
- Sponsor
- Sun Yat-sen University
Who can join
- Age
- 18 to 75 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 4
- Minimum age: 18 years
- Maximum age: 75 years
- Study condition: Rectal Cancer Patients, Robotic Assisted Intervention
- ECOG performance status 0-1. Informed consent obtained.
Exclusion 1
- Pregnancy or lactation. Severe psychiatric illness. Other malignancies within 5 years. Severe comorbidities or infections making surgery intolerable. Judged unsuitable by investigator.
Where
1 site, 1 recruiting
the sixth affiliated hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Contact
-
Liang Kang, MD
+8613602886833 kangl@mail.sysu.edu.cn
-
Ling Shuang Luo, MD
+8613751756175 kangl@mail.sysu.edu.cn
Potential match only. Final eligibility is determined by the study team.